LitPet®, one of many UK’s quickest rising science led pet wellness manufacturers, is unveiling three new clinically engineered merchandise at PATS 2026. (stand J56)
The launch continues the momentum of an organization based lower than two years in the past, born from a deeply private catalyst: the sudden lack of founder Stephen Hu’s British Shorthair cat, Kung Hey, to a stress associated urinary situation. This second uncovered a serious hole within the complement market — power stress and underlying well being imbalances have been being ignored, whereas most merchandise targeted solely on floor stage signs.
Stephen’s analysis journey led him to discover Conventional Chinese language Drugs (TCM) alongside fashionable biomedical science. With analysis groups in London and Hong Kong and collaborations with specialists skilled at Oxford, Cambridge and Johns Hopkins College, LitPet® is dedicated to medical rigour, sustainability and significant group influence. LitPet works with scientists whose work focuses on collagen biology, metabolic pathways, mucosal absorption, and dietary modulation of power inflammatory situations. This twin self-discipline strategy — Jap natural philosophy mixed with Western medical methodology — varieties the inspiration of LitPet’s product growth.
Since launching in 2025, LitPet has achieved fast trade recognition, together with Gold for Most Promising New Begin Up and Silver for Greatest New Product on the PetQuip Awards, and finalist positions on the PIF Innovation Awards 2025 & 2026.
THE NEW PRODUCT RANGE
FLEXIGUARD® — Superior Joint & Mobility Help Powder
FlexiGuard® is designed as a every day meal topper that helps joint consolation, cartilage construction and long run mobility. Joint stiffness impacts as much as 37% of canines and 40% of cats, with joint degradation impacting greater than 80% of senior canines and 90% of senior cats. Tablets typically result in rejection and poor compliance; FlexiGuard® solves this by delivering medical grade actives in a extremely palatable powder.
On the core of the system is Xelflex®, a patented hydrolysed collagen peptide matrix developed utilizing analysis methodologies originating from Oxford and Cambridge biomedical labs. These peptides have been proven in vivo to considerably scale back joint swelling and oedema at 50mg/kg, supporting cartilage resilience, synovial fluid integrity and collagen fibre restore. FlexiGuard® builds on this basis with glucosamine HCl, MSM, turmeric and yucca, making a complete 5 approach strategy to mobility help.
The product provides distinctive worth for pet dad and mom, offering as much as a 90 day provide for small pets at underneath 28p per day, and is manufactured in Eire underneath strict high quality requirements.
PROJOINT® ADVANCED ORAL GEL
ProJoint® Oral Gel is engineered for pets who refuse capsules or have diminished urge for food — a problem highlighted repeatedly in LitPet’s buyer suggestions. The gel delivers quick performing mobility help by direct to mouth dosing utilizing an included calibrated syringe.
Its efficacy comes from Kynosil®, a bioactive compound at 7.5mg/ml that absorbs by the oral mucosa, bypassing slower liver metabolism. This sublingual route permits Kynosil® to behave shortly on collagen fibre cross linking (Varieties I, II and III), supporting connective tissue density, ligament energy and cartilage restore. The mucosal absorption mannequin utilized in ProJoint® displays analysis rules taught inside Oxford’s physiology departments and Cambridge’s veterinary medication programmes, the place oral mucosal supply is recognised for its velocity and effectivity.
The pure salmon flavour eliminates capsule swallowing stress, and the product is on the market in each 30ml trial dimension and 60ml worth dimension. ProJoint® is manufactured within the UK in GMP licensed amenities, in line with LitPet’s dedication to medical rigour and third occasion testing.
METABOLIC ORAL GEL — Species Particular Formulation for Canine & Cats
With 50% of UK canines and 43% of cats categorised as obese, pet homeowners more and more want protected, non medicinal help for sustaining a wholesome physique situation. LitPet’s Metabolic Oral Gel supplies this by species particular formulation calibrated to canine and feline glycaemic pathways — a distinction typically ignored in generic weight administration dietary supplements.
The gel is powered by Pep2Dia®, delivering 75mg/ml of patented bioactive peptides clinically validated to inhibit α glucosidase within the small gut. This slows carbohydrate breakdown, reduces put up meal glucose spikes and helps every day satiety. In a 60 day feline medical trial (15mg/kg twice every day), Pep2Dia® produced a 24% discount in fasting blood glucose and a 4.5% discount in physique weight.
LitPet (Stand J56) PATS 27 – 29 September.
